Literature DB >> 19706389

The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response.

Leandro Castellano1, Georgios Giamas, Jimmy Jacob, R Charles Coombes, Walter Lucchesi, Paul Thiruchelvam, Geraint Barton, Long R Jiao, Robin Wait, Jonathan Waxman, Gregory J Hannon, Justin Stebbing.   

Abstract

Following estrogenic activation, the estrogen receptor-alpha (ERalpha) directly regulates the transcription of target genes via DNA binding. MicroRNAs (miRNAs) modulated by ERalpha have the potential to fine tune these regulatory systems and also provide an alternate mechanism that could impact on estrogen-dependent developmental and pathological systems. Through a microarray approach, we identify the subset of microRNAs (miRNAs) modulated by ERalpha, which include upregulation of miRNAs derived from the processing of the paralogous primary transcripts (pri-) mir-17-92 and mir-106a-363. Characterization of the mir-17-92 locus confirms that the ERalpha target protein c-MYC binds its promoter in an estrogen-dependent manner. We observe that levels of pri-mir-17-92 increase earlier than the mature miRNAs derived from it, implicating precursor cleavage modulation after transcription. Pri-mir-17-92 is immediately cleaved by DROSHA to pre-miR-18a, indicating that its regulation occurs during the formation of the mature molecule from the precursor. The clinical implications of this novel regulatory system were confirmed by demonstrating that pre-miR-18a was significantly upregulated in ERalpha-positive compared to ERalpha-negative breast cancers. Mechanistically, miRNAs derived from these paralogous pri-miRNAs (miR-18a, miR-19b, and miR-20b) target and downregulate ERalpha, while a subset of pri-miRNA-derived miRNAs inhibit protein translation of the ERalpha transcriptional p160 coactivator, AIB1. Therefore, different subsets of miRNAs identified act as part of a negative autoregulatory feedback loop. We propose that ERalpha, c-MYC, and miRNA transcriptional programs invoke a sophisticated network of interactions able to provide the wide range of coordinated cellular responses to estrogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706389      PMCID: PMC2747188          DOI: 10.1073/pnas.0906947106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

Review 2.  Connections and regulation of the human estrogen receptor.

Authors:  Donald P McDonnell; John D Norris
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 3.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 4.  Estrogen receptor pathways to AP-1.

Authors:  P J Kushner; D A Agard; G L Greene; T S Scanlan; A K Shiau; R M Uht; P Webb
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

Review 5.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

6.  Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA.

Authors:  Inha Heo; Chirlmin Joo; Jun Cho; Minju Ha; Jinju Han; V Narry Kim
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

7.  Coactivator AIB1 links estrogen receptor transcriptional activity and stability.

Authors:  Wenlin Shao; Erika Krasnickas Keeton; Donald P McDonnell; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

8.  Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels.

Authors:  Nicola Micali; Carmelo Ferrai; Luis C Fernandez-Diaz; Francesco Blasi; Massimo P Crippa
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

9.  miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA.

Authors:  Deo Prakash Pandey; Didier Picard
Journal:  Mol Cell Biol       Date:  2009-05-04       Impact factor: 4.272

10.  The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs.

Authors:  Michele Trabucchi; Paola Briata; Mariaflor Garcia-Mayoral; Astrid D Haase; Witold Filipowicz; Andres Ramos; Roberto Gherzi; Michael G Rosenfeld
Journal:  Nature       Date:  2009-05-20       Impact factor: 49.962

View more
  162 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

Review 2.  Micro-RNAs and breast cancer.

Authors:  John Le Quesne; Carlos Caldas
Journal:  Mol Oncol       Date:  2010-04-28       Impact factor: 6.603

3.  microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

4.  Hormone replacement therapy dependent changes in breast cancer-related gene expression in breast tissue of healthy postmenopausal women.

Authors:  Anieta M Sieuwerts; Giuseppina De Napoli; Anne van Galen; Helenius J Kloosterboer; Vanja de Weerd; Hong Zhang; John W M Martens; John A Foekens; Christian De Geyter
Journal:  Mol Oncol       Date:  2011-09-16       Impact factor: 6.603

5.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

Review 6.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

Review 7.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

8.  Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p.

Authors:  Carlos Marino Cabral Calvano Filho; Daniele Carvalho Calvano-Mendes; Kátia Cândido Carvalho; Gustavo Arantes Maciel; Marcos Desidério Ricci; Ana Paula Torres; José Roberto Filassi; Edmund Chada Baracat
Journal:  Tumour Biol       Date:  2014-05-09

9.  VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.

Authors:  Prashant K Singh; Mark D Long; Sebastiano Battaglia; Qiang Hu; Song Liu; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  Epigenetics       Date:  2015-01-29       Impact factor: 4.528

10.  High FUT3 expression is a marker of lower overall survival of breast cancer patients.

Authors:  Jessica Catarine Frutuoso do Nascimento; Eduardo Isidoro Carneiro Beltrão; Cíntia Renata Costa Rocha
Journal:  Glycoconj J       Date:  2020-02-15       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.